相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Persistence of allospecific helper T cells is required for maintaining autoantibody formation in lupus-like graft-versus-host disease
L. ROZENDAAL et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Rituximab reduces the incidence of acute graft-versus-host disease
Maximilian Christopeit et al.
BLOOD (2009)
Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease
Stefanie Sarantopoulos et al.
BLOOD (2009)
Proportions of immature CD19+CD21- B lymphocytes predict the response to extracorporeal photopheresis in patients with chronic graft-versus-host disease
Zoya Kuzmina et al.
BLOOD (2009)
Influence of bone marrow graft B lymphocyte subsets on outcome after HLA-identical sibling transplants
David Michonneau et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation
Voravit Ratanatharathorn et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Rituximab for the treatment of corticosteroid-refractory chronic graft-versus-host disease
Takanori Teshima et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2009)
Elevated numbers of immature/transitional CD2I- B lymphocytes and deficiency of memory CD27+ B cells identify patients with active chronic graft-versus-host disease
Hildegard T. Greinix et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Statins inhibit human APC function: implications for the treatment of GVHD
Alexander Shimabukuro-Vornhagen et al.
BLOOD (2008)
The impact of HMG-CoA reductase inhibition on the incidence and severity of graft-versus-host disease in patients with acute leukemia undergoing allogeneic transplantation
Mehdi Hamadani et al.
BLOOD (2008)
Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab
Issa F. Khouri et al.
BLOOD (2008)
Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab
Roberto Stasi et al.
BLOOD (2008)
Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group
Hisaki Fujii et al.
BLOOD (2008)
Rituximab as salvage therapy for refractory chronic GVHD
M. Mohty et al.
BONE MARROW TRANSPLANTATION (2008)
Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cells
Neil C. Robson et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
B-cell depletion with Rituximab in relapsing-remitting multiple sclerosis
Stephen L. Hauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The 'short' history of regulatory B cells
Claudia Mauri et al.
TRENDS IN IMMUNOLOGY (2008)
Successful therapy of chronic graft-versus-host disease manifesting as pure red cell aplasia with single-agent rituximab
D. M. Benson et al.
BONE MARROW TRANSPLANTATION (2008)
Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity
Robert Zeiser et al.
BLOOD (2007)
High levels of B-cell activating factor in patients with active chronic graft-versus-host disease
Stefanie Sarantopoulos et al.
CLINICAL CANCER RESEARCH (2007)
Naive B cells generate regulatory T cells in the presence of a mature immunologic synapse
Peter Reichardt et al.
BLOOD (2007)
Cutting edge:: Primary B lmphocytes preferentially expand allogeneic FoxP3+ CD4 T cells
Xinjian Chen et al.
JOURNAL OF IMMUNOLOGY (2007)
Treatment of refractory chronic GVHD with rituximab: a GITMO study
F. Zaja et al.
BONE MARROW TRANSPLANTATION (2007)
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease
Silvia Svegliati et al.
BLOOD (2007)
Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond
M. Mohty
LEUKEMIA (2007)
The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukeryiia
Ronjon Chakraverty et al.
BLOOD (2007)
Rituximab is effective for extensive steroid-refractory chronic graft-vs.-host-disease
Angelo Michele Carella et al.
LEUKEMIA & LYMPHOMA (2007)
Rituximab responsive refractory acute graft-versus-host disease
R. Kamble et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
B cells drive early T cell autoimmunity in vivo prior to dendritic cell-mediated autoantigen presentation
Jun Yan et al.
JOURNAL OF IMMUNOLOGY (2006)
Host B cells produce IL-10 following TBI and attenuate acute GVHD after allogeneic bone marrow transplantation
Vanessa Rowe et al.
BLOOD (2006)
Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemia
P. Kebriaei et al.
BONE MARROW TRANSPLANTATION (2006)
Rituximab for steroid-refractory chronic graft-versus-host disease
Corey Cutler et al.
BLOOD (2006)
Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations
CY Zhang et al.
BLOOD (2006)
The development of autoantibodies after allogeneic stem cell transplantation is related with chronic graft-vs-host disease and immune recovery
F Patriarca et al.
EXPERIMENTAL HEMATOLOGY (2006)
Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. Response Criteria Working Group report
SZ Pavletic et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Rituximab is effective for steroid-refractory sclerodermatous chronic graft-versus-host disease
M Okamoto et al.
LEUKEMIA (2006)
Genetic variation in the IL-10 pathway modulates severity of acute graft-versus-host disease following hematopoietic cell transplantation:: synergism between IL-10 genotype of patient and IL-10 receptor β genotype of donor
MT Lin et al.
BLOOD (2005)
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report
AH Filipovich et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Concerted antigen presentation by dendritic cells and B cells is necessary for optimal CD4 T-cell immunity in vivo
P Kleindienst et al.
IMMUNOLOGY (2005)
Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission
DB Miklos et al.
BLOOD (2005)
Allogeneic peripheral blood stem cell graft composition affects early T-cell chimaerism and later clinical outcomes after non-myeloablative conditioning
JP Panse et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
B cells activated in lymph nodes in response to ultraviolet irradiation or by interleukin-10 inhibit dendritic cell induction of immunity
SN Byrne et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Down-regulation of CD40 and CD80 on B cells in patients with life-threatening systemic lupus erythematosus after successful treatment with rituximab
M Tokunaga et al.
RHEUMATOLOGY (2005)
Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation
E Zorn et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Complete response to donor lymphocyte infusion in multiple myeloma is associated with antibody responses to highly expressed antigens
R Bellucci et al.
BLOOD (2004)
Donor APCs are required for maximal GVHD but not for GVL
CC Matte et al.
NATURE MEDICINE (2004)
Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors
DB Miklos et al.
BLOOD (2004)
Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus
JH Anolik et al.
ARTHRITIS AND RHEUMATISM (2004)
Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus-host disease
MR Canninga-van Dijk et al.
BLOOD (2004)
Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic cell transplantation
M Lin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning
M Maris et al.
EXPERIMENTAL HEMATOLOGY (2003)
Predominant autoantibody production by early human B cell precursors
H Wardemann et al.
SCIENCE (2003)
Rituximab reduces relapse risk after allogeneic and autologous stem cell transplantation in patients with high-risk aggressive non-Hodgkin's lymphoma
A Shimoni et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody
V Ratanatharathorn et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2003)
A comparison of T-, B- and NK-cell reconstitution following conventional or nonmyeloablative conditioning and transplantation with bone marrow or peripheral blood stem cells from human leucocyte antigen identical sibling donors
SL Petersen et al.
BONE MARROW TRANSPLANTATION (2003)
B cells activated by lipopolysaccharide, but not by anti-Ig and anti-CD40 antibody, induce anergy in CD8+ T cells:: Role of TGF-β1
VV Parekh et al.
JOURNAL OF IMMUNOLOGY (2003)
APCs in the liver and spleen recruit, activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease
Y Zhang et al.
JOURNAL OF IMMUNOLOGY (2002)
Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study
M Mohty et al.
BLOOD (2002)
T lymphocytes potentiate murine dendritic cells to produce IL-12
A Rizzitelli et al.
JOURNAL OF IMMUNOLOGY (2002)
B cells regulate autoimmunity by provision of IL-10
S Fillatreau et al.
NATURE IMMUNOLOGY (2002)
Immunologic effects of prophylactic donor lymphocyte infusion after allogeneic marrow transplantation for multiple myeloma
R Bellucci et al.
BLOOD (2002)
Preterminal host dendritic cells in irradiated mice prime CD8+ T cell-mediated acute graft-versus-host disease
Y Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: potential for clinical application
MS von Bergwelt-Baildon et al.
BLOOD (2002)
B cells and professional APCs recruit regulatory T cells via CCL4
RS Bystry et al.
NATURE IMMUNOLOGY (2001)
Enhanced activation of B cells in a granulocyte colony-stimulating factor-mobilized peripheral blood stem cell graft
H Tayebi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Effect of extended immunosuppressive drug treatment on B cell vs T cell reconstitution in pediatric bone marrow transplant recipients
S D'Costa et al.
BONE MARROW TRANSPLANTATION (2001)
Factors influencing B lymphopoiesis after allogeneic hematopoietic cell transplantation
J Storek et al.
BLOOD (2001)
Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation
J Storek et al.
BLOOD (2001)
Reciprocal regulation of polarized cytokine production by effector B and T cells
DP Harris et al.
NATURE IMMUNOLOGY (2000)
B lymphocytes regulate dendritic cell (DC) function in vivo: Increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation
V Moulin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease
V Ratanatharathorn et al.
ANNALS OF INTERNAL MEDICINE (2000)
Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation
E Holler et al.
BONE MARROW TRANSPLANTATION (2000)
Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia
CJ Wu et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
分享论文
